Engaging a technology partner who specializes in tools and services geared toward both your trial supply and sustainability goals is essential when optimizing your clinical supply. The recent rise in gas prices, limited availability of drugs and API resources, expensive comparator drugs, sensitive compounds, short IP expiration dates, and resulting inflation have introduced even more logistical challenges and increased cost pressure.
To achieve precise supply chain modeling and forecasting, teams need to engage an IRT partner capable of automating supply strategies based on real-time trial data and has deep partnerships in global logistics.
Hear from IRT industry veteran and drug supply expert Stefan Dürr on how to reduce the impact of both traditional and emerging macroeconomic pressures on the clinical supply chain. Viewers will discover why optimizing trial supply is more critical than ever, ways to save on shipping and IP costs, how to impact the cold chain through automated optimization, and more.